|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization of premises and equipment | |||||
| Other net (accretion) amortization | |||||
| Provision for credit losses | |||||
| Net securities gains | |||||
| Mortgage banking income | |||||
| Stock compensation expense | |||||
| Decrease (increase) in deferred income tax assets, net | |||||
| Increase in cash surrender value of bank-owned life insurance | |||||
| Loans originated for sale | |||||
| Proceeds from the sale of loans originated for sale | |||||
| Net change in: accrued interest receivable and other assets | |||||
| Net change in: accrued interest payable and other liabilities | |||||
| Other—net | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Net increase in loans held for investment | |||||
| Available-for-sale debt securities: | |||||
| Proceeds from sales | |||||
| Proceeds from maturities, prepayments and calls | |||||
| Purchases of securities | |||||
| Held-to-maturity debt securities: | |||||
| Proceeds from maturities, prepayments and calls | |||||
| Purchases of securities | |||||
| Net cash received from the PFC acquisition | |||||
| Sale of portfolio loans - net | |||||
| Purchases of bank owned life insurance | |||||
| Proceeds from bank owned life insurance | |||||
| Purchases of premises and equipment—net | |||||
| Net cash used in investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Increase in deposits | |||||
| Proceeds from Federal Home Loan Bank borrowings | |||||
| Repayment of Federal Home Loan Bank borrowings | |||||
| (Decrease) increase in other short-term borrowings | |||||
| Principal repayments of finance lease obligations | |||||
| Repayment of junior subordinated debt, net of discount and subordinated debt | |||||
| Dividends paid to common shareholders | |||||
| Dividends paid to preferred shareholders | |||||
| Issuance of preferred stock, Series B, net of issuance costs | |||||
| Issuance of common stock, net of equity issuance costs | |||||
| Redemption of preferred stock, Series A | |||||
| Redemption premium on preferred stock, Series A | |||||
| Treasury shares (purchased) sold-net | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of the year | |||||
| Cash, cash equivalents and restricted cash at end of the year | |||||
| SUPPLEMENTAL DISCLOSURES | |||||
| Interest paid on deposits and other borrowings | |||||
| Income taxes paid | |||||
| Transfers of loans to other real estate owned | |||||
| Transfers of loans held for sale to portfolio loans | |||||
| Transfers of portfolio loans to loans held for sale | |||||
| Non-cash transactions related to the PFC acquisition | |||||
Loading...